Myriad Genetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A.

CEO

Samraat S Raha

CEOSamraat S Raha

Employees

2,700

Employees2,700

Headquarters

Salt Lake City, Utah

HeadquartersSalt Lake City, Utah

Founded

1991

Founded1991

Employees

2,700

Employees2,700

MYGN Key Statistics

Market cap

485.31M

Market cap485.31M

Price-Earnings ratio

-4.71

Price-Earnings ratio-4.71

Dividend yield

—

Dividend yield—

Average volume

1.65M

Average volume1.65M

High today

$5.50

High today$5.50

Low today

$5.17

Low today$5.17

Open price

$5.35

Open price$5.35

Volume

1.88M

Volume1.88M

52 Week high

$29.30

52 Week high$29.30

52 Week low

$3.81

52 Week low$3.81

MYGN News

Simply Wall St 3d

Myriad Genetics, Inc. Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Those holding Myriad Genetics, Inc. ( ) shares would be relieved that the share price has rebounded 29% in the last thirty days, but it needs to keep going to r...

Analyst ratings

56%

of 16 ratings

Buy

18.8%

Hold

56.3%

Sell

25%

People also own

Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.